Colorectal Cancer Coalition

C3 Comments Publicly on CT-Colonography

C3 commented publicly this week to the Centers for Medicare and Medicaid Services (CMS) regarding the reimbursement of CT-Colonography (CTC), also known as Virtual Colonoscopies. CMS offered the opportunity to comment during their National Coverage Analysis (NCA).

The American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology issued revised guidelines for colorectal cancer screening in March 2008. Their rigorous, evidence-based evaluation of the various screening methods resulted in the addition of CTC to the screening guidelines. This decision opened up the question whether or not Medicare should begin covering CTC the same way it covers fecal occult blood tests (FOBTs), barium enemas, flexible sigmoidoscopy and colonoscopy.

Despite the passage of the Balanced Budget Act (BBA) of 1997, which authorized coverage for colorectal cancer screenings for Medicare recipients, colorectal cancer screenings are still very much under-used. The Centers for Disease Control and Prevention (CDC) estimates that as many as 60 percent of deaths could be prevented if everyone age 50 and older were screened regularly. One of the barriers to screening is patient concern about an invasive procedure such as colonoscopy and flexible sigmoidoscopy. CTC gives an attractive alternative for patients.

Click here to read C3’s comments

C3 fully supports the coverage of CTC by Medicare and believes that all Americans should have full access to credible colorectal cancer screening. In addition to submitting comments to CMS we have publicly endorsed legislation in Congress, The Virtual Screening for Cancer Act (HR 4879). This legislation would give authority to CMS to begin covering CTC under Medicare.

This news article was originally posted on June 18th, 2008 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Joe Arite on June 18th, 2008
Tags: CMS, Congress, CTC, HR 4879, Medicare, Screenings

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Name Email (hidden) URL Comments (Basic HTML is allowed - a href, strong, em, blockquote)